99 filings
8-K
EDIT
Editas Medicine Inc
8 May 24
Editas Medicine Announces First Quarter 2024 Results and Business Updates
7:08am
8-K
EDIT
Editas Medicine Inc
28 Feb 24
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
7:06am
8-K
EDIT
Editas Medicine Inc
13 Dec 23
Regulation FD Disclosure
9:02am
8-K
EDIT
Editas Medicine Inc
11 Dec 23
Regulation FD Disclosure
4:23pm
8-K
EDIT
Editas Medicine Inc
22 Nov 23
Departure of Directors or Certain Officers
4:10pm
8-K
nkltaxyfi985p oke
3 Nov 23
Editas Medicine Announces Third Quarter 2023 Results and Business Updates
7:06am
8-K
1ihayw28t
10 Oct 23
Departure of Directors or Certain Officers
4:05pm
8-K
a0qb5jkums7
2 Aug 23
Editas Medicine Announces Second Quarter 2023 Results and Business Updates
7:16am
8-K
gs1sl
15 Jun 23
Editas Medicine Announces Offering of Common Stock
4:30pm
8-K
63jo86g9
9 Jun 23
Regulation FD Disclosure
6:01am
8-K
4ek7k536mweiz dz33y
5 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
pbkgjq
17 May 23
Departure of Directors or Certain Officers
4:30pm
8-K
bg09jdjte8bmm1d a5w
5 May 23
Editas Medicine Announces First Quarter 2023 Results and Business Updates
7:16am
8-K
tfyyv3f4xpd5
13 Apr 23
Departure of Directors or Certain Officers
5:09pm
8-K
72h pqmmrn0tq
14 Mar 23
Departure of Directors or Certain Officers
4:45pm
8-K
du7wydkaydc07bj4d
22 Feb 23
Editas Medicine Announces Fourth Quarter and Full Year 2022 Results and Business Updates
6:31am
8-K
pzktgiyzd
9 Jan 23
Departure of Directors or Certain Officers
8:36am
8-K
8dz7upzthizyxwado
6 Dec 22
Other Events
6:41am
8-K
v96cq
17 Nov 22
Editas Medicine Announces Clinical Data Demonstrating Proof of Concept of EDIT-101 from Phase 1/2 BRILLIANCE Trial
7:30am
8-K
156pn9
2 Nov 22
Editas Medicine Announces Third Quarter 2022 Results and Business Updates
6:49am